Schedule I - Cash Flow (Details) - USD ($)
$ in Thousands
 3 Months Ended 12 Months Ended
May 29, 2015
Dec. 31, 2016
Sep. 30, 2016
Jun. 30, 2016
Mar. 31, 2016
Dec. 31, 2015
Sep. 30, 2015
Jun. 30, 2015
Mar. 31, 2015
Dec. 31, 2016
Dec. 31, 2015
Dec. 31, 2014
Condensed Financial Statements, Captions [Line Items]                        
Net loss   $ (20,234) $ (21,235) $ (18,839) $ (21,066) $ (8,880) $ (23,279) $ 2,849 $ (9,235) $ (81,374) $ (38,545) $ (28,376)
Adjustments to reconcile net loss to net cash provided by operating activities:                        
Amortization of deferred loan costs and discount                   3,542 2,446 1,242
Payment-in-kind interest capitalized                   15,396 8,507 481
(Benefit) Provision for deferred income tax                   (8,020) (38,435) 2,182
Changes in assets and liabilities that relate to operations:                        
Prepaid expenses                   2,021 (1,466) (1,349)
Accounts payable and accrued liabilities                   12,567 (4,770) 2,791
Net cash provided by (used in) operating activities                   34,493 9,403 12,482
Cash flows from investing activities                        
Net cash used in investing activities                   (40,629) (401,850) (33,922)
Cash flows from financing activities                        
Proceeds from issuance of debt                   0 369,400 0
Proceeds from Issuance of Common Stock $ 77,400                 0 77,425 0
Proceeds from employees in advance of common stock issuance                   75 579 1,969
Repurchase of shares issued to management                   (50) (1,277) 0
Payment of deferred loan costs                   0 (3,837) (73)
Net cash provided by financing activities                   (11,603) 417,547 9,860
Increase (decrease) in cash and cash equivalents                   (17,745) 25,042 (11,062)
Cash and cash equivalents, beginning of period         35,722       10,680 35,722 10,680 21,742
Cash and cash equivalents, end of period   17,977       35,722       17,977 35,722 10,680
Non-cash investing and financing activities:                        
Incurrance of Amaya Seller Note                   0 17,233 11,500
Parent Company [Member]                        
Condensed Financial Statements, Captions [Line Items]                        
Net loss                   (81,374) (38,545) (28,376)
Adjustments to reconcile net loss to net cash provided by operating activities:                        
Amortization of deferred loan costs and discount                   340 143 0
Payment-in-kind interest capitalized                   14,819 7,980 0
Equity in net loss of subsidiaries                   62,450 33,405 26,870
(Benefit) Provision for deferred income tax                   3,528 (3,528) 0
Changes in assets and liabilities that relate to operations:                        
Prepaid expenses                   23 6 (69)
Intercompany payable/receivable                   148 455 455
Accounts payable and accrued liabilities                   35 (24) 24
Net cash provided by (used in) operating activities                   (31) (108) (1,096)
Cash flows from investing activities                        
Investment in subsidiaries                   (15,720) (172,484) (11,635)
Distributions received from subsidiaries                   0 1,322 2,737
Net cash used in investing activities                   (15,720) (171,162) (8,898)
Cash flows from financing activities                        
Proceeds from issuance of debt                   0 111,550 0
Proceeds from Issuance of Common Stock                   0 77,425 0
Proceeds from employees in advance of common stock issuance                   0 579 1,969
Repurchase of shares issued to management                   (50) (277) 0
Payment of deferred loan costs                   0 (548) 0
Net cash provided by financing activities                   (50) 188,729 1,969
Increase (decrease) in cash and cash equivalents                   (15,801) 17,459 (8,025)
Cash and cash equivalents, beginning of period         $ 25,972       $ 8,513 25,972 8,513 16,538
Cash and cash equivalents, end of period   $ 10,171       $ 25,972       10,171 25,972 8,513
Non-cash investing and financing activities:                        
Subsidiary payment for share repurchase on Company’s behalf                   0 1,000 0
Intercompany payable settled as distribution                   0 890 0
Incurrance of Amaya Seller Note                   $ 0 $ 12,000 $ 0